montelukast actavis
actavis group ptc ehf - montelukast - montelukast
montelukast aurobindo pharma italia
aurobindo pharma (italia) s.r.l. - montelukast - montelukast
nanoalbumon
radiopharmacy laboratory ltd - tecnezio-99mtc-nanocolloide - tecnezio-99mtc-nanocolloide
montelukast ahcl
accord healthcare, s.l.u. - montelukast - montelukast
sodio ioduro (131i) ge
ge healthcare s.r.l. - sodio ioduro (131i) - sodio ioduro (131i)
amiped
b. braun melsungen ag - aminoacidi - aminoacidi
esomeprazolo hospira
hospira italia s.r.l. - esomeprazolo - esomeprazolo
montelukast unimark remedies
unimark remedies s.r.o. - montelukast - montelukast
adcirca (previously tadalafil lilly)
eli lilly nederland b.v. - tadalafil - ipertensione, polmonare - urologici - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. l'efficacia è stata dimostrata nella pah idiopatica (ipah) e nella pah correlata alla malattia vascolare del collagene. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.
aubagio
sanofi winthrop industrie - teriflunomide - sclerosi multipla - immunosoppressori selettivi - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).